LP420400-6
Cabotegravir
Active
Description
Cabotegravir is an investigational drug being developed for the treatment and prevention of infection by the human immunodeficiency virus 1 (HIV-1). It is an integrase strand transfer inhibitor (INSTI) that binds to the HIV-1 integrase enzyme and prevents viral DNA integration into the host genome and blocks HIV-1 reproduction. Cabotegravir can be taken orally in tablet form or as an injection. The most common side effects have been described as mild or moderate and include injection site reaction, fatigue, fever, headache, and nausea. Other rare but more serious side effects include arthritis of the knee, presyncope, sudden onset of pancreatitis, allergic reaction, vertigo, weakness, gastrointestinal problems, rash, and neurological issues.[https://clinicalinfo.hiv.gov/en/drugs/cabotegravir/health-professional] Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Cabotegravir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2020-10-02
- Construct for LOINC Short Name
- Cabotegravir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP420400-6
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| nl-NL | Dutch (Netherlands) | cabotegravir |
| it-IT | Italian (Italy) | Cabotegravir |
| es-ES | Spanish (Spain) | Cabotegravir |
| zh-CN | Chinese (China) | 卡博特韦 Synonyms: 长效HIV整合酶抑制剂; |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright